Khedidja Bouachi

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease

Hélène Munyentwali, Khedidja Bouachi, Vincent Audard et al. · Kidney International · 2013 · 150 citations

Rheumatology, Medicine, Safe Treatment +4

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Cécile Couchoud, Florian Bayer, Carole Ayav et al. · Kidney International · 2020 · 150 citations · Full text

Hemodialysis, Medicine, Covid-19 Pandemic +9

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

Hassan Izzedine, M. Mangier, Virginie Ory et al. · Kidney International · 2013 · 100 citations · Full text

Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy

Kélhia Sendeyo, Vincent Audard, Shaoyu Zhang et al. · Kidney International · 2013 · 35 citations · Full text

Glomerular Disease, Glomerulonephritis, Renal Function +13

An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study)

Philippe Rémy, Vincent Audard, Pierre André Natella et al. · Kidney International · 2018 · 28 citations

Enteric-coated Mycophenolate Sodium, Open-label Randomized, Chronic Kidney Disease +3